跳至主要内容
临床试验/IRCT201206079963N1
IRCT201206079963N1已完成未知

Effects of Botulinium Toxin -A in perennial allergic rhinitis patients resistant to conventional treatments

niversity of Social Welfare and Rehabilitation sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 40 years(—)
性别
All

入选标准

  • Males and females age between 20-40; Having perennial (minimum of three years) allergic rhinitis who have received conventional treatments with no results; Having a minimum educational level ( high school diploma); Being stable in emotional,physical and other health status suitable for entering study ; Informed consent to be understood and be signed voluntarily.
  • Exclusion criteria:
  • Ages below 20 or above 40 years; History of chronic sinusitis,asthma and or other systemic disoredrs ; History of using Botulinium Toxin type -A for any reason; Rejecting to accept and or signing the informed consent.

排除标准

  • 未提供

研究者

发起方
niversity of Social Welfare and Rehabilitation sciences

相似试验

Unknown
1 期
Effects of Botulinum toxin A addition to allergen specific immunotherapy for treating Allergic Rhinitispatients with allergic rhinitis, age between 18-60 years oldBotulinum toxins A, Immunotherapy, Allergic Rhinitis, Vasomotor Rhinitis
TCTR20220914004Faculty of Medicine of Chulalongkorn University92
尚未招募
不适用
Assessment of Botulinum Toxin Type A in the Treatment of Hand EczemaHand Eczema
PACTR201704002194318Dermatology Department, Faculty of Medicine, University of Alexandria60
进行中(未招募)
不适用
Effect of Botulinum Toxin A Injections and Specific Intensive Rehabilitation Therapy in Children with Hemiparetic Cerebral Palsy on Upper Limb Functions and Skills - BoBiVa (Botuline toxine Bimanuele Vaardigheden)Study design: a factorial design with four study groups in which btA alone, intensive rehabilitation therapy aimed at improving bimanual skills alone, a combination of these two and continuing the regular therapy program will be compared to each other.Study population: children with CP, spastic hemiparesis, aged 2.5 – 12 years.
EUCTR2006-002175-40-NL60
已完成
3 期
Effect of Botulinum Toxin A Injections and Specific Intensive Rehabilitation Therapy in Children with Hemiparetic Cerebral Palsy on Upper Limb Functions and Skillscongenital hemiparesisSpastic hemiparetic cerebral palsy10010335
NL-OMON30186Hoensbroek Revalidatiecentrum (HRC)60
已完成
不适用
Assessment of efficacy of Botulinium toxin A for treatment of keloidkeloid scar.Hypertrophic scar
IRCT2014071918533N1euronox company(Tehran reseller)20